Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dylan Matvey"'
Autor:
Huiyu Hu, Thomas S. Ng, Mikyung Kang, Ella Scott, Ran Li, Jeremy M. Quintana, Dylan Matvey, Venkata R. Vantaku, Ralph Weissleder, Sareh Parangi, Miles A. Miller
Publikováno v:
Cancer Research. 83:3067-3067
Background: The non-specific uptake of extracellular materials through macropinocytosis can fuel tumor growth and survival, and is especially studied in cancer-types that frequently harbor RAS or PTEN mutations. However, relatively little data descri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f45c4cd45dea61392ac797dd85d2a955
https://doi.org/10.1158/1538-7445.am2023-3067
https://doi.org/10.1158/1538-7445.am2023-3067
Autor:
Thomas S. C. Ng, Huiyu Hu, Stefan Kronister, Chanseo Lee, Ran Li, Luca Gerosa, Sylwia A. Stopka, Danielle M. Burgenske, Ishaan Khurana, Michael S. Regan, Sreeram Vallabhaneni, Niharika Putta, Ella Scott, Dylan Matvey, Anita Giobbie-Hurder, Rainer H. Kohler, Jann N. Sarkaria, Sareh Parangi, Peter K. Sorger, Nathalie Y. R. Agar, Heather A. Jacene, Ryan J. Sullivan, Elizabeth Buchbinder, Hannes Mikula, Ralph Weissleder, Miles A. Miller
Publikováno v:
Science Advances. 8
BRAF-targeted kinase inhibitors (KIs) are used to treat malignancies including BRAF-mutant non–small cell lung cancer, colorectal cancer, anaplastic thyroid cancer, and, most prominently, melanoma. However, KI selection criteria in patients remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac64a8f0be30d2199cb941578a506532
https://doi.org/10.1126/sciadv.abl6339
https://doi.org/10.1126/sciadv.abl6339
Publikováno v:
Drug Week; 12/29/2023, p574-574, 1p